- Technological advancements
- Increase in the aging population
- Quantitative increase in in-vitro diagnostic tests globally
- Increased awareness about health and diagnostic tests amongst the population
- Increasing prevalence of chronic diseases
- Increased focus on reduction of healthcare costs
- Rising number of point-of-care testing capabilities
According to the report, the increasing number of crimes is also fuelling the growth of the market since clinical chemistry testing plays an important role in criminal investigations. However, the report also identifies the market constraints as high cost, need for highly qualified and trained personnel, and risk of result uncertainty.
The report classifies the market on the basis of types of products, end users, sectors and more. Products include reagents and analyzers and end-users comprise hospitals, diagnostic laboratories, and academic research institutes. Types of sectors include ultra-large, large, mid and small sector clinical chemistry analyzers. Geographically, North America is considered the most dominating market and the Asia-Pacific region is expected to be the market with the fastest growth during the forecast period.
Key players in the chemistry analyzers market that are planning to launch new versions of devices to address the unmet needs include Beckman Coulter, Nova Biomedical Corporation, Abbott Diagnostics, Siemens AG, Thermo Fisher Scientific, Inc., Elitech Group, Mindray Medical International Limited, and Sysmex Corporation.